April 28, 2021
BioAge Labs is off to a fast start in 2021, with two drugs in its pipeline now undergoing clinical trials and a third planned to start in the near future. BioAge Labs Building momentum After a $90 million Series C funding round closed late last year, BioAge has moved quickly to start the new year....
March 03, 2021
BioAge, in a recent press release, has announced the start of its phase 2a clinical trial in elderly patients with unexplained anemia of aging. BioAge is a California-based company founded in 2015 with a very direct focus on aging. It utilizes a systems biology approach and AI-based drug discovery platform to target important pathways which...